* Medifast Inc MED.N MED is expected to show a rise in
quarterly revenue when it reports results on May 4.
* The Owings Mills, Maryland-based company is expected to report
a 56.3% increase in revenue to $278.89 million from $178.46
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $2.73 per share. For the same quarter last year, the
company reported earnings of $1.93 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Medifast Inc is
$301, about 24.6% above its last closing price of $227.09.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 2.37 2.38 2.36 Missed -0.8
Sep. 30 2020 2.54 2.46 2.91 Beat 18.5
Jun. 30 2020 1.84 1.83 1.96 Beat 7
Mar. 31 2020 1.31 1.33 1.93 Beat 45.4
Dec. 1.08 1.07 1.66 Beat 54.5
31 2019
Sep. 30 2019 1.34 1.34 1.32 Missed -1.2
Jun. 30 2019 1.72 1.72 1.75 Beat 1.6
Mar. 31 2019 1.54 1.54 1.70 Beat 10.6
This summary was machine generated May 1 at 02:06 GMT. All
figures in US dollars unless otherwise stated